See more : Ayala Corporation (AYALY) Income Statement Analysis – Financial Results
Complete financial analysis of ALK-Abelló A/S (ALK-B.CO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ALK-Abelló A/S, a leading company in the Biotechnology industry within the Healthcare sector.
- Findi Limited (FND.AX) Income Statement Analysis – Financial Results
- Freeport Resources Inc. (FRI.V) Income Statement Analysis – Financial Results
- Tencent Music Entertainment Group (TME) Income Statement Analysis – Financial Results
- Founder Group Limited Ordinary Shares (FGL) Income Statement Analysis – Financial Results
- Cloudbreak Discovery Plc (CDL.L) Income Statement Analysis – Financial Results
ALK-Abelló A/S (ALK-B.CO)
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. It product portfolio include GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers much earlier in the disease journey through tools and e-commerce offerings that supports, guidance and relief, and smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intramuscular injection of adrenaline for the treatment of acute life-threatening allergic reactions including Anaphylaxis. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.82B | 4.51B | 3.92B | 3.49B | 3.27B | 2.92B | 2.91B | 3.01B | 2.57B | 2.43B | 2.24B | 2.35B | 2.35B | 2.14B | 1.94B | 1.78B | 1.65B | 1.49B | 1.22B | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.79B | 1.72B | 1.52B | 1.46B | 1.38B | 1.28B | 1.27B | 994.00M | 836.00M | 736.00M | 697.00M | 648.00M | 611.00M | 653.00M | 587.00M | 527.00M | 499.00M | 497.00M | 413.00M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 3.04B | 2.79B | 2.40B | 2.03B | 1.89B | 1.63B | 1.64B | 2.01B | 1.73B | 1.70B | 1.55B | 1.70B | 1.74B | 1.49B | 1.35B | 1.26B | 1.15B | 992.00M | 804.00M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 62.91% | 61.87% | 61.18% | 58.09% | 57.79% | 56.02% | 56.43% | 66.92% | 67.46% | 69.75% | 68.94% | 72.37% | 73.98% | 69.49% | 69.66% | 70.46% | 69.79% | 66.62% | 66.06% | 0.00% | 0.00% | 0.00% |
| Research & Development | 618.00M | 665.00M | 631.00M | 515.00M | 466.00M | 392.00M | 426.00M | 385.00M | 407.00M | 394.00M | 463.00M | 511.00M | 455.00M | 366.00M | 349.00M | 327.00M | 323.00M | 282.00M | 232.00M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 331.00M | 276.00M | 240.00M | 237.00M | 246.00M | 227.00M | 231.00M | 198.00M | 190.00M | 199.00M | 192.00M | 203.00M | 204.00M | 208.00M | 188.00M | 178.00M | 179.00M | 176.00M | 167.00M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 1.42B | 1.38B | 1.23B | 1.13B | 1.21B | 1.14B | 1.07B | 893.00M | 843.00M | 795.00M | 762.00M | 801.00M | 781.00M | 743.00M | 672.00M | 658.00M | 640.00M | 482.00M | 358.00M | 0.00 | 0.00 | 0.00 |
| SG&A | 1.75B | 1.66B | 1.47B | 1.36B | 1.46B | 1.36B | 1.30B | 1.09B | 1.03B | 994.00M | 954.00M | 1.00B | 985.00M | 951.00M | 860.00M | 836.00M | 819.00M | 658.00M | 525.00M | 0.00 | 0.00 | 0.00 |
| Other Expenses | -2.00M | -1.00M | -1.00M | 0.00 | 0.00 | -27.00M | -2.00M | -7.00M | 0.00 | -4.00M | -1.00M | 0.00 | -2.00M | -22.00M | -37.00M | -25.00M | -207.00M | -1.00M | 45.00M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.37B | 2.32B | 2.10B | 1.88B | 1.92B | 1.73B | 1.72B | 1.47B | 1.44B | 1.38B | 1.42B | 1.52B | 1.44B | 1.30B | 1.17B | 1.14B | 935.00M | 939.00M | 802.00M | 0.00 | 0.00 | 0.00 |
| Cost & Expenses | 4.16B | 4.04B | 3.62B | 3.34B | 3.30B | 3.01B | 2.99B | 2.46B | 2.28B | 2.12B | 2.11B | 2.16B | 2.05B | 1.95B | 1.76B | 1.67B | 1.43B | 1.44B | 1.22B | 0.00 | 0.00 | 0.00 |
| Interest Income | 12.00M | 4.00M | 1.00M | 5.00M | 17.00M | 12.00M | 17.00M | 13.00M | 3.00M | 2.00M | 0.00 | 9.00M | 30.00M | 21.00M | 17.00M | 40.00M | 43.00M | 42.00M | 14.00M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 22.00M | 24.00M | 23.00M | 34.00M | 34.00M | 25.00M | 16.00M | 14.00M | 14.00M | 11.00M | 11.00M | 11.00M | 8.00M | 6.00M | 2.00M | 2.00M | 4.00M | 2.00M | 80.00M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 244.00M | 236.00M | 222.00M | 207.00M | 225.00M | 193.00M | 181.00M | 163.00M | 159.00M | 226.00M | 135.00M | 124.00M | 137.00M | 116.00M | 102.00M | 86.00M | 98.00M | 73.00M | 57.00M | 0.00 | 0.00 | 0.00 |
| EBITDA | 913.00M | 705.00M | 524.00M | 311.00M | 228.00M | 115.00M | 75.00M | 655.00M | 572.00M | 455.00M | 242.00M | 248.00M | 436.00M | 308.00M | 277.00M | 245.00M | 316.00M | 168.00M | 71.00M | 0.00 | 0.00 | 0.00 |
| EBITDA Ratio | 18.93% | 15.72% | 13.89% | 10.91% | 7.57% | 5.49% | 8.04% | 24.19% | 22.34% | 20.14% | 10.87% | 13.30% | 18.57% | 14.39% | 14.32% | 13.73% | 19.13% | 11.22% | 5.83% | 0.00% | 0.00% | 0.00% |
| Operating Income | 666.00M | 470.00M | 292.00M | 150.00M | -7.00M | -72.00M | -99.00M | 479.00M | 415.00M | 264.00M | 109.00M | 188.00M | 299.00M | 192.00M | 175.00M | 159.00M | 218.00M | 53.00M | 2.00M | 0.00 | 0.00 | 0.00 |
| Operating Income Ratio | 13.81% | 10.42% | 7.46% | 4.30% | -0.21% | -2.47% | -3.40% | 15.94% | 16.15% | 10.85% | 4.86% | 8.02% | 12.73% | 8.97% | 9.04% | 8.91% | 13.20% | 3.56% | 0.16% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -19.00M | -23.00M | -13.00M | -49.00M | -17.00M | -7.00M | -42.00M | 8.00M | -15.00M | 36.00M | -25.00M | -5.00M | 22.00M | 15.00M | 15.00M | 38.00M | 14.00M | 40.00M | -68.00M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 647.00M | 447.00M | 279.00M | 101.00M | -31.00M | -103.00M | -122.00M | 487.00M | 400.00M | 300.00M | 104.00M | 113.00M | 321.00M | 207.00M | 190.00M | 157.00M | 232.00M | 93.00M | -66.00M | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 13.41% | 9.91% | 7.12% | 2.89% | -0.95% | -3.53% | -4.19% | 16.21% | 15.57% | 12.33% | 4.63% | 4.82% | 13.67% | 9.67% | 9.82% | 8.80% | 14.04% | 6.25% | -5.42% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 161.00M | 112.00M | 60.00M | 76.00M | 19.00M | 67.00M | 36.00M | 217.00M | 56.00M | 119.00M | 43.00M | 59.00M | 121.00M | 79.00M | 72.00M | 62.00M | 92.00M | 49.00M | 2.00M | 0.00 | 0.00 | 0.00 |
| Net Income | 486.00M | 335.00M | 219.00M | 25.00M | -50.00M | -170.00M | -158.00M | 270.00M | 344.00M | 181.00M | 61.00M | 54.00M | 200.00M | 128.00M | 118.00M | 95.00M | 140.00M | 24.00M | 4.30B | 0.00 | 0.00 | 0.00 |
| Net Income Ratio | 10.07% | 7.43% | 5.59% | 0.72% | -1.53% | -5.83% | -5.43% | 8.99% | 13.39% | 7.44% | 2.72% | 2.30% | 8.52% | 5.98% | 6.10% | 5.33% | 8.47% | 1.61% | 353.49% | 0.00% | 0.00% | 0.00% |
| EPS | 2.20 | 1.52 | 1.00 | 0.11 | -0.23 | -0.78 | -0.80 | 1.38 | 1.77 | 0.94 | 0.32 | 0.28 | 1.01 | 0.65 | 0.59 | 0.48 | 0.70 | 0.12 | 21.40 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 2.20 | 1.51 | 0.99 | 0.11 | -0.23 | -0.78 | -0.79 | 1.36 | 1.75 | 0.92 | 0.31 | 0.28 | 1.01 | 0.65 | 0.59 | 0.48 | 0.70 | 0.12 | 21.40 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 221.15M | 220.50M | 219.39M | 218.32M | 218.01M | 217.33M | 198.43M | 196.33M | 194.09M | 193.20M | 193.20M | 194.91M | 197.94M | 198.22M | 199.19M | 199.88M | 200.53M | 202.02M | 201.07M | 10.13M | 10.13M | 10.13M |
| Weighted Avg Shares Out (Dil) | 221.28M | 221.37M | 220.99M | 219.89M | 218.01M | 218.18M | 199.26M | 198.27M | 196.88M | 197.56M | 195.49M | 195.76M | 197.95M | 198.22M | 199.19M | 199.89M | 201.27M | 202.07M | 201.07M | 10.13M | 10.13M | 10.13M |
Source: https://incomestatements.info
Category: Stock Reports